Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/95924
DC FieldValueLanguage
dc.contributor.authorAlves, Francisco-
dc.contributor.authorAntunes, Inês F-
dc.contributor.authorCazzola, Emiliano-
dc.contributor.authorCleeren, Frederik-
dc.contributor.authorCornelissen, Bart-
dc.contributor.authorDenkova, Antonia-
dc.contributor.authorEngle, Jonathan-
dc.contributor.authorFaivre-Chauvet, Alain-
dc.contributor.authorGillings, Nic-
dc.contributor.authorHendrikx, Jeroen J M A-
dc.contributor.authorJalilian, Amir R-
dc.contributor.authorvan der Meulen, Nicholas P-
dc.contributor.authorMikolajczak, Renata-
dc.contributor.authorNeels, Oliver C-
dc.contributor.authorPillai, Maroor R A-
dc.contributor.authorReilly, Raymond-
dc.contributor.authorRubow, Sietske-
dc.contributor.authorSeimbille, Yann-
dc.contributor.authorSpreckelmeyer, Sarah-
dc.contributor.authorSzymanski, Wiktor-
dc.contributor.authorTaddei, Carlotta-
dc.date.accessioned2021-10-21T10:01:28Z-
dc.date.available2021-10-21T10:01:28Z-
dc.date.issued2021-09-08-
dc.identifier.issn2365-421Xpt
dc.identifier.urihttps://hdl.handle.net/10316/95924-
dc.description.abstractBackground: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biyearly highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Results: This commentary of highlights has resulted in 21 different topics selected by each member of the Editorial Board addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Also the first contribution in relation to MRI-agents is included. Conclusions: Trends in (radio)chemistry and radiopharmacy are highlighted demonstrating the progress in the research field being the scope of EJNMMI Radiopharmacy and Chemistry. © 2021, The Author(s).pt
dc.description.sponsorshipOpen Access funding enabled and organized by Projekt DEAL. Financial support from EJNMMI Radiopharmacy and Chemistry to make this review article available for Open Access is gratefully acknowledged.pt
dc.language.isoengpt
dc.publisherSpringer Naturept
dc.relationProjekt DEALpt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectHighlight selectionpt
dc.subjectRadiochemistrypt
dc.subjectRadiopharmacypt
dc.titleHighlight selection of radiochemistry and radiopharmacy developments by editorial boardpt
dc.typearticle-
degois.publication.firstPage31pt
degois.publication.issue1pt
degois.publication.titleEJNMMI Radiopharmacy and Chemistrypt
dc.peerreviewedyespt
dc.identifier.doi10.1186/s41181-021-00146-9pt
degois.publication.volume6pt
dc.date.embargo2021-09-08*
uc.date.periodoEmbargo0pt
item.openairetypearticle-
item.fulltextCom Texto completo-
item.languageiso639-1en-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.orcid0000-0001-8054-4267-
Appears in Collections:I&D ICNAS - Artigos em Revistas Internacionais
IIIUC - Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
s41181-021-00146-9.pdf1.4 MBAdobe PDFView/Open
Show simple item record

Page view(s)

122
checked on Jul 16, 2024

Download(s)

77
checked on Jul 16, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons